Barely Significant
← all excerpts

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.

Immun Ageing · 2017 · PMC5389002 · PMID 28413427

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

near-significantp = 0.06so close (0.05 < p ≤ 0.1)
2c , the 90 μg antigen dose produced stronger responses, with or without aluminum phosphate, relative to the 60 μg dose, eliciting a near-significant 1.4-fold increase in response to unadjvuanted formulations (p = 0.06) and a significant 1.3-fold increase in response to adjvuanted formulations (p = 0.022,) on day 56.

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.